Jasper Therapeutics Ownership | Who Owns Jasper Therapeutics?

Jasper Therapeutics Ownership Summary

Jasper Therapeutics is owned by 83.22% institutional investors, 1.17% insiders, and 15.61% retail investors. Soleus capital management is the largest institutional shareholder, holding 9.95% of JSPR shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.85% of its assets in Jasper Therapeutics shares.

JSPR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Jasper Therapeutics	83.22%	1.17%	15.61%
Sector	Healthcare Stocks	218.58%	11.00%	-129.58%
Industry	Biotech Stocks	296.15%	10.91%	-207.06%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Soleus capital management	1.49M	9.95%	$8.29M
Carlyle group	1.07M	7.10%	$5.92M
T. rowe price investment management	703.65K	4.68%	$3.91M
Kingdon capital management	684.71K	4.56%	$3.80M
Integral health asset management	590.00K	3.93%	$3.27M
Rock springs capital management lp	545.17K	3.63%	$3.03M
Blackrock funding, inc. /de	225.60K	1.50%	$1.25M
Marshall wace, llp	50.69K	0.34%	$281.31K
Xtx topco	27.35K	0.18%	$151.78K
Mariner	25.51K	0.17%	$141.60K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Soleus capital management	1.49M	0.55%	$8.29M
Kingdon capital management	684.71K	0.51%	$3.80M
Integral health asset management	590.00K	0.30%	$3.27M
Rock springs capital management lp	545.17K	0.19%	$3.03M
Carlyle group	1.07M	0.12%	$5.92M
Corton capital	10.00K	0.06%	$55.52K
Ikarian capital	25.11K	0.03%	$139.34K
Sphera funds management	14.67K	0.02%	$81.42K
Sequent planning	10.50K	0.02%	$58.27K
Xtx topco	27.35K	0.01%	$151.78K

Top Buyers

Holder	Shares	% Assets	Change
Kingdon capital management	684.71K	0.51%	194.71K
Marshall wace, llp	50.69K	0.00%	50.69K
Xtx topco	27.35K	0.01%	27.35K
Integral health asset management	590.00K	0.30%	15.00K
Hrt financial lp	14.80K	0.00%	14.80K

Top Sellers

Holder	Shares	% Assets	Change
Braidwell lp	-	-	-714.66K
Samsara biocapital	-	-	-584.64K
Blackrock funding, inc. /de	225.60K	-	-562.00K
Opaleye management	-	-	-400.00K
Great point partners	-	-	-322.38K

New Positions

Holder	Shares	% Assets	Change	Value
Xtx topco	27.35K	0.01%	27.35K	$151.78K
Hrt financial lp	14.80K	0.00%	14.80K	$82.00K
Sequent planning	10.50K	0.02%	10.50K	$58.27K
Massmutual trust co fsb/adv	145.00	-	145.00	$805.00
Eversource wealth advisors	65.00	-	65.00	$361.00

Sold Out

Holder	Change
Sterling capital management	-12.00
Wolff wiese magana	-15.00
Coldstream capital management	-38.00
Nisa investment advisors	-53.00
Greenline partners	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	65	-2.99%	12,501,153	8.39%	83	1.33%	35	16.67%	15	-34.78%
Mar 31, 2025	70	-24.73%	13,034,411	-16.69%	89	0.78%	32	-38.46%	23	35.29%
Dec 31, 2024	92	10.84%	15,645,934	6.60%	107	1.12%	51	15.91%	17	-10.53%
Sep 30, 2024	83	18.57%	14,676,954	0.82%	97	1.04%	44	-	19	111.11%
Jun 30, 2024	70	9.38%	14,557,013	11.80%	97	1.02%	44	25.71%	9	-62.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Polar Capital Healthcare Opports Inc	581.54K	3.85%	-
T. Rowe Price Small-Cap Value	437.64K	2.91%	-512.00
Vanguard Total Stock Mkt Idx Inv	412.11K	2.54%	-9.01K
Franklin Biotechnology Discv A(acc)USD	339.25K	2.26%	-
iShares Russell 2000 ETF	285.63K	1.90%	-
HBM Healthcare Investments AG Ord	250.00K	1.67%	-
T. Rowe Price U.S. SC Value Eq Tr-D	247.05K	1.64%	1.24K
T. Rowe Price U.S. SC Value Eq Tr-Z	245.81K	1.64%	217.41K
Fidelity Select Health Care	208.04K	1.39%	208.04K
Franklin Biotechnology Discovery A	195.44K	1.30%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$19.90K
Sep 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$19.10K
Jun 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$21.74K
Mar 12, 2024	Mahal Jeetinder Singh	Chief Operating Officer	Sell	$23.79K
Feb 08, 2024	Carlyle Group Inc.	Former 10% Owner	Buy	$2.46M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	1
2024 Q3	-	1

JSPR Ownership FAQ

Who Owns Jasper Therapeutics?

Jasper Therapeutics shareholders are primarily institutional investors at 83.22%, followed by 1.17% insiders and 15.61% retail investors. The average institutional ownership in Jasper Therapeutics's industry, Biotech Stocks , is 296.15%, which Jasper Therapeutics falls below.

Who owns the most shares of Jasper Therapeutics?

Jasper Therapeutics’s largest shareholders are Soleus capital management (1.49M shares, 9.95%), Carlyle group (1.07M shares, 7.10%), and T. rowe price investment management (703.65K shares, 4.68%). Together, they hold 21.73% of Jasper Therapeutics’s total shares outstanding.

Does Blackrock own Jasper Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Jasper Therapeutics.

Who is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested?

Soleus capital management is Jasper Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.55% of its assets in 1.49M Jasper Therapeutics shares, valued at 8.29M$.

Who is the top mutual fund holder of Jasper Therapeutics shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Jasper Therapeutics shares, with 3.85% of its total shares outstanding invested in 581.54K Jasper Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools